Effect of lenalidomide therapy on hematopoiesis of patients with myelodysplastic syndrome associated with chromosome 5q deletion

BACKGROUND: Lenalidomide improves erythropoiesis in patients with low/intermediate-1 risk myelodysplastic syndrome and interstitial deletion of the long arm of chromosome 5 [del(5q)]. The aim of this study was to explore the effect of lenalidomide treatment on the reserves and functional characteris...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Ximeri, Maria, Galanopoulos, Athanasios, Klaus, Mirjam, Parcharidou, Agapi, Giannikou, Krinio, Psyllaki, Maria, Symeonidis, Argyrios, Pappa, Vasiliki, Kartasis, Zafiris, Liapi, Dimitra, Hatzimichael, Eleftheria, Kokoris, Styliani, Korkolopoulou, Penelope, Sambani, Constantina, Pontikoglou, Charalampos, Papadaki, Helen A.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Ferrata Storti Foundation 2010
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2833070/
https://ncbi.nlm.nih.gov/pubmed/19773257
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2009.010876
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller